Santen Pharmaceutical promises a strong presence at this week’s World Ophthalmology Congress (WOC) in Barcelona, Spain, June 16-19, 2018.
“We’re privileged the World Congress of Ophthalmology is in Europe this year and it promises to be Santen’s strongest congress yet,” Luis Iglesias, President and Head of EMEA, said in a company news release. “We have grown to be a business whose products are supplied in more than 50 markets in the EMEA region with an exciting time ahead of us with future launches and pipeline products. It’s a great time to showcase Santen as a leader in ophthalmology.”
In addition to scientific and educational presentations, Santen is a Gold Sponsor and exhibitor at WOC and will be available at booth #5033.
In nine scientific sessions, data on Santen clinical studies or on Santen products will be presented, including cyclosporine A cationic emulsion for severe vernal keratoconjunctivitis (VKC), the Innfocus Microshunt surgical device for glaucoma, intravitreal sirolimus, and others.
Santen sponsored educational symposia:
Sat 16 June, 12.15-13.30: Dry eye disease: Breaking the vicious cycle matters. Hall 8.1
Chaired by Prof. Margarita Calonge Valladolid University, Spain
The objectives of this symposium are to examine the role of inflammation in dry eye disease and to highlight how cyclosporine A cationic emulsion breaks the underlying inflammatory vicious cycle, thus improving the condition of the cornea in dry eye disease patients with keratitis.
Sun 17 June, 12.15-13.30: Continuing glaucoma control during day and night. Room 5
Chaired by Prof. Ki Ho Park Seoul National University, Korea and Prof. Julián García Feijóo, Hospital Clínico San Carlos, Universidad Complutense Madrid, Spain
During this symposium, experts in the field will provide an overview of the role and clinical relevance of circadian fluctuations on different measures of ocular health in normal tension and open-angle glaucoma. Additionally, the faculty will present data and clinical cases providing insights into the importance of 24-hour IOP and ocular blood flow control for minimising glaucomatous progression.
Mon 18 June, 12.15-13.30: More than meets the eye: Different perspectives on the pathophysiology and management of dry eye disease. Room 5
Chaired by Prof. Shigeru Kinoshita, Kyoto Prefectural University of Medicine, Japan
Today, it is understood that dry eye disease (DED) is multifactorial. This symposium will focus on the mechanism and treatment of DED from different perspectives.
For more information on the symposia, please visit: http://www.santen.com/en/woc/index.html